Expression Profiles of Long Noncoding RNAs in Intranasal LPS-Mediated Alzheimer's Disease Model in Mice

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2019 Feb 28

PMID 30809552

Citations 27

Authors

Liang Tang

Lan Liu

Guangyi Li

Pengcheng Jiang

Yan Wang

Jianming Li

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD), characterized by memory loss, cognitive decline, and dementia, is a progressive neurodegenerative disease. Although the long noncoding RNAs (lncRNAs) have recently been identified to play a role in the pathogenesis of AD, the specific effects of lncRNAs in AD remain unclear. In present study, we have investigated the expression profiles of lncRNAs in hippocampal of intranasal LPS-mediated Alzheimer's disease models in mice by microarray method. A total of 395 lncRNAs and 123 mRNAs was detected to express differently in AD models and controls (>2.0 folds, <0.05). The microarray expression was validated by Quantitative Real-Time-PCR (qRT-PCR). The pathway analysis showed the mRNAs that correlated with lncRNAs were involved in inflammation, apoptosis, and nervous system related pathways. The lncRNA-TFs network analysis suggested the lncRNAs were mostly regulated by HMGA2, ONECUT2, FOXO1, and CDC5L. Additionally, lncRNA-target-TFs network analysis indicated the FOXL1, CDC5L, ONECUT2, and CDX1 to be the TFs most likely to regulate the production of these lncRNAs. This is the first study to investigate lncRNAs expression pattern in intranasal LPS-mediated Alzheimer's disease model in mice. And these results may facilitate the understanding of the pathogenesis of AD targeting lncRNAs.

Citing Articles

Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease.

Wang H, Zhao M, Chen G, Lin Y, Kang D, Yu L Sci Rep. 2024; 14(1):17478.

PMID: 39080336 PMC: 11289109. DOI: 10.1038/s41598-024-68585-3.

Expression of ITPR2 regulated by lncRNA-NONMMUT020270.2 in LPS-stimulated HT22 cells.

Liu L, Tang L, Wang Y, Liu S, Zhang Y Heliyon. 2024; 10(13):e33491.

PMID: 39040287 PMC: 11260991. DOI: 10.1016/j.heliyon.2024.e33491.

Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions.

Prasanth M, Sivamaruthi B, Cheong C, Verma K, Tencomnao T, Brimson J Antioxidants (Basel). 2024; 13(5).

PMID: 38790711 PMC: 11118909. DOI: 10.3390/antiox13050606.

The emerging role and mechanism of HMGA2 in breast cancer.

Ma Q, Ye S, Liu H, Zhao Y, Zhang W J Cancer Res Clin Oncol. 2024; 150(5):259.

PMID: 38753081 PMC: 11098884. DOI: 10.1007/s00432-024-05785-4.

Systems genetics analysis reveals the common genetic basis for pain sensitivity and cognitive function.

Xu F, Chen A, Pan S, Wu Y, He H, Han Z CNS Neurosci Ther. 2024; 30(2):e14557.

PMID: 38421132 PMC: 10850811. DOI: 10.1111/cns.14557.

References

Donjacour A, Sciavolino P, Kim M, Desai N, Young P, Norton C . Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999; 13(8):966-77. PMC: 316645. DOI: 10.1101/gad.13.8.966. View

Kang D, Soriano S, Frosch M, Collins T, Naruse S, Sisodia S . Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J Neurosci. 1999; 19(11):4229-37. PMC: 6782616. View

Kar S, Quirion R . Amyloid beta peptides and central cholinergic neurons: functional interrelationship and relevance to Alzheimer's disease pathology. Prog Brain Res. 2003; 145:261-74. DOI: 10.1016/S0079-6123(03)45018-8. View

Ohno M, Sametsky E, Younkin L, Oakley H, Younkin S, Citron M . BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron. 2004; 41(1):27-33. DOI: 10.1016/s0896-6273(03)00810-9. View

Hellstrom I, Danik M, Luheshi G, Williams S . Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus. 2005; 15(5):656-64. DOI: 10.1002/hipo.20086. View

Rogaeva E, Meng Y, Lee J, Gu Y, Kawarai T, Zou F . The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007; 39(2):168-77. PMC: 2657343. DOI: 10.1038/ng1943. View

Vorhees C, Williams M . Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2007; 1(2):848-58. PMC: 2895266. DOI: 10.1038/nprot.2006.116. View

Mus E, Hof P, Tiedge H . Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A. 2007; 104(25):10679-84. PMC: 1965572. DOI: 10.1073/pnas.0701532104. View

Kawabata S, Higgins G, Gordon J . Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Nature. 1991; 354(6353):476-8. DOI: 10.1038/354476a0. View

10.

Parenti R, Paratore S, Torrisi A, Cavallaro S . A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. Eur J Neurosci. 2007; 26(9):2444-57. DOI: 10.1111/j.1460-9568.2007.05864.x. View

11.

Faghihi M, Modarresi F, Khalil A, Wood D, Sahagan B, Morgan T . Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008; 14(7):723-30. PMC: 2826895. DOI: 10.1038/nm1784. View

12.

Perez S, Lumayag S, Kovacs B, Mufson E, Xu S . Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease. Invest Ophthalmol Vis Sci. 2008; 50(2):793-800. PMC: 3697019. DOI: 10.1167/iovs.08-2384. View

13.

Filali M, Lalonde R, Rivest S . Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav. 2008; 8(2):143-8. DOI: 10.1111/j.1601-183X.2008.00453.x. View

14.

Belarbi K, Schindowski K, Burnouf S, Caillierez R, Grosjean M, Demeyer D . Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease. Curr Alzheimer Res. 2009; 6(2):152-7. PMC: 2859345. DOI: 10.2174/156720509787602843. View

15.

Massone S, Vassallo I, Fiorino G, Castelnuovo M, Barbieri F, Borghi R . 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis. 2010; 41(2):308-17. DOI: 10.1016/j.nbd.2010.09.019. View

16.

Chen X, Cao X, Tao G, Cao Z, Wang S, Zhou F . FOXJ2 expression in rat spinal cord after injury and its role in inflammation. J Mol Neurosci. 2012; 47(1):158-65. DOI: 10.1007/s12031-011-9704-2. View

17.

Massone S, Ciarlo E, Vella S, Nizzari M, Florio T, Russo C . NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. Biochim Biophys Acta. 2012; 1823(7):1170-7. DOI: 10.1016/j.bbamcr.2012.05.001. View

18.

Jonsson T, Atwal J, Steinberg S, Snaedal J, Jonsson P, Bjornsson S . A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012; 488(7409):96-9. DOI: 10.1038/nature11283. View

19.

Ciarlo E, Massone S, Penna I, Nizzari M, Gigoni A, Dieci G . An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples. Dis Model Mech. 2012; 6(2):424-33. PMC: 3597024. DOI: 10.1242/dmm.009761. View

20.

Anand R, Gill K, Mahdi A . Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology. 2013; 76 Pt A:27-50. DOI: 10.1016/j.neuropharm.2013.07.004. View